Progress in Strategies for Dosage Regimen Individualization | Bentham Science
Generic placeholder image

Current Topics in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1568-0266
ISSN (Online): 1873-4294

Progress in Strategies for Dosage Regimen Individualization

Author(s): Hafedh Marouani, Christian Woloch, Stephan Benay, Nicolas Frances and Athanassios Iliadis

Volume 12, Issue 15, 2012

Page: [1669 - 1677] Pages: 9

DOI: 10.2174/156802612803531315

Price: $65

Open Access Journals Promotions 2
Abstract

Several findings suggest that patient outcome would be improved with individualized doses. The aim of this paper is to describe major approaches, methods and underlying basic foundations implemented, in clinical practice, for dosage individualization. Also we propose a new method codified by kinetic nomograms as reliable alternative to traditional Bayesian methods. Clinical and simulation data were reported to evaluate performances of the proposed methods. Real examples of therapeutic drug monitoring were selected. Bayesian methods were used to individualize high-dose methotrexate rate infusion and amikacin dosage regimen, and kinetic nomograms to adjust sirolimus doses. 1) Using only few measurements, Bayesian method resulted in accurate estimates of individual pharmacokinetic parameters of highdose methotrexate infusion. Targeting a pre-defined end-of-infusion level, infusion rate was individualized according to the previously obtained pharmacokinetic parameters. 2) With the same reasoning, individual pharmacokinetic parameters of amikacin were obtained by Bayesian estimation using three individual samples. Subsequent dosage adjustment allowed achievement of therapeutic goals at steady state. 3) Without computing individual pharmacokinetic parameters, nor using pharmacokinetic software, kinetic nomograms steered individual sirolimus blood levels within its therapeutic window with only two samples and in the first week after starting treatment. This contribution relates traditional Bayesian methods developed in 80’s but not yet fully integrated in clinical context because of their complexity. The contribution focuses on recent developments based on population approaches, rendering the dosage adjustment methodology a simple and quick bedside application.

Keywords: Bayesian estimation, dosage adjustment, inter-individual variability, pharmacokinetics, population approaches, therapeutic drug monitoring


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy